ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

Guy Newell, Anderson’s First Prevention Expert Past NCI Deputy, Dead

November 25, 1994